User profiles for Remo Andrea
andrea remoAULSS9, Verona (Italy) Verified email at aulsslegnago.it Cited by 2518 |
Genetic and epigenetic events generate multiple pathways in colorectal cancer progression
M Pancione, A Remo… - Pathology research …, 2012 - Wiley Online Library
Colorectal cancer (CRC) is one of the most common causes of death, despite decades of
research. Initially considered as a disease due to genetic mutations, it is now viewed as a …
research. Initially considered as a disease due to genetic mutations, it is now viewed as a …
Morphology and molecular features of rare colorectal carcinoma histotypes
Several histopathological variants of colorectal carcinoma can be distinguished, some associated
with specific molecular profiles. However, in routine practice, ninety/ninety-five percent …
with specific molecular profiles. However, in routine practice, ninety/ninety-five percent …
Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis
M Pancione, G Giordano, A Remo… - Journal of …, 2014 - Wiley Online Library
Over the past decade, growing evidence indicates that the tumor microenvironment (TME)
contributes with genomic/epigenomic aberrations of malignant cells to enhance cancer cells …
contributes with genomic/epigenomic aberrations of malignant cells to enhance cancer cells …
[HTML][HTML] Delphi initiative for early-onset colorectal cancer (DIRECt) international management guidelines
Background & Aims Patients with early-onset colorectal cancer (eoCRC) are managed
according to guidelines that are not age-specific. A multidisciplinary international group (DIRECt), …
according to guidelines that are not age-specific. A multidisciplinary international group (DIRECt), …
Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivoanalysis
Background Obesity in postmenopausal women is associated with increased breast cancer
risk, development of more aggressive tumors and resistance to certain anti-breast cancer …
risk, development of more aggressive tumors and resistance to certain anti-breast cancer …
Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification: Evaluation According to ASCO/CAP Criteria
…, G Martignoni, K Miller, A Remo… - American journal of …, 2009 - academic.oup.com
We evaluated intratumoral heterogeneity of 30 ductal breast carcinomas with HER2/neu
amplification, scored by the American Society of Clinical Oncology/ College of American …
amplification, scored by the American Society of Clinical Oncology/ College of American …
Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in …
…, D Parente, N Forte, A Fabozzi, A Remo… - Journal of experimental …, 2015 - Springer
Background Cancer-related immune antigens in the tumor microenvironment could represent
an obstacle to agents targeting EGFR “cetuximab” or VEGF “bevacizumab” in metastatic …
an obstacle to agents targeting EGFR “cetuximab” or VEGF “bevacizumab” in metastatic …
[HTML][HTML] Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice
The pathologist emerged in the personalized medicine era as a central actor in the
definition of the most adequate diagnostic and therapeutic algorithms. In the last decade, …
definition of the most adequate diagnostic and therapeutic algorithms. In the last decade, …
Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic …
Background and Aims EUS-guided through-the-needle biopsy (TTNB) sampling has been
reported to improve diagnostic yield compared with cytology for the evaluation of pancreatic …
reported to improve diagnostic yield compared with cytology for the evaluation of pancreatic …
Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARγ and TNFα signaling
…, M Pancione, L Sabatino, C Votino, A Remo… - PLoS …, 2013 - journals.plos.org
We describe a novel bioinformatic and translational pathology approach, gene Signature
Finder Algorithm (gSFA) to identify biomarkers associated with Colorectal Cancer (CRC) …
Finder Algorithm (gSFA) to identify biomarkers associated with Colorectal Cancer (CRC) …